HDII (Hypertension Diagnostics) Cash Receipts from Operating Activities

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc. is a medical device company based in the United States that developed and marketed the CVProfilor, a non-invasive device for assessing arterial compliance and vascular health. The CVProfilor system uses a blood pressure cuff and proprietary sensor technology to measure large and small artery elasticity, providing clinicians with information intended to help detect cardiovascular disease risk earlier than traditional blood pressure measurement alone. The company targeted primary care physicians, cardiologists, and other healthcare providers as its customers, selling its devices and related disposable components through a direct sales force and distributor relationships, primarily in the United States. Revenue came from device sales and recurring sales of single-use sensors and accessories. The company has faced financial difficulties and its operations have been limited in recent years.